3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole

C111H136BrFN22O14Si3 — CID 163775315

About 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole

3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole (PubChem CID 163775315) has the molecular formula C111H136BrFN22O14Si3 and a molecular weight of 2185.61 g/mol. Its IUPAC name is 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole.

Molecular Properties

• Compound Name: 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole
• PubChem CID: 163775315
• Molecular Formula: C111H136BrFN22O14Si3
• Molecular Weight: 2185.61 g/mol
• Exact Mass: 2182.91
• IUPAC Name: 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole
• SMILES: C[Si](C)(C)CCOCn1cc(Br)nc1C1COc2ccc(O)cc2C1.Cc1cc(-c2cn(COCC[Si](C)(C)C)c(C3COc4ccc(O)cc4C3)n2)n(C)n1.Cc1cc(-c2cn(COCC[Si](C)(C)C)c(C3COc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)n2)n(C)n1.Cc1cc(-c2cnc(C3COc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)[nH]2)n(C)n1.Cc1cc(C)n(C)n1.O=C1CCc2c(F)ccnc2N1
• InChI: InChI=1S/C31H38N6O4Si.C25H24N6O3.C23H32N4O3Si.C18H25BrN2O3Si.C8H7FN2O.C6H10N2/c1-20-14-26(36(2)35-20)25-17-37(19-39-12-13-42(3,4)5)31(33-25)22-15-21-16-23(6-8-27(21)40-18-22)41-28-10-11-32-30-24(28)7-9-29(38)34-30;1-14-9-20(31(2)30-14)19-12-27-24(28-19)16-10-15-11-17(3-5-21(15)33-13-16)34-22-7-8-26-25-18(22)4-6-23(32)29-25;1-16-10-21(26(2)25-16)20-13-27(15-29-8-9-31(3,4)5)23(24-20)18-11-17-12-19(28)6-7-22(17)30-14-18;1-25(2,3)7-6-23-12-21-10-17(19)20-18(21)14-8-13-9-15(22)4-5-16(13)24-11-14;9-6-3-4-10-8-5(6)1-2-7(12)11-8;1-5-4-6(2)8(3)7-5/h6,8,10-11,14,16-17,22H,7,9,12-13,15,18-19H2,1-5H3,(H,32,34,38);3,5,7-9,11-12,16H,4,6,10,13H2,1-2H3,(H,27,28)(H,26,29,32);6-7,10,12-13,18,28H,8-9,11,14-15H2,1-5H3;4-5,9-10,14,22H,6-8,11-12H2,1-3H3;3-4H,1-2H2,(H,10,11,12);4H,1-3H3
• InChIKey: MJXOJWYBSIPELR-UHFFFAOYSA-N
• XLogP: 20.46
• TPSA: 402.92 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 32
• Rotatable Bonds: 26
• Heavy Atoms: 152
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2185.61
LogP ≤ 5	20.46
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	32

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole?

The IUPAC name of 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole (CID 163775315) is 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole.

What is the SMILES notation for 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole?

The canonical SMILES for 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole is C[Si](C)(C)CCOCn1cc(Br)nc1C1COc2ccc(O)cc2C1.Cc1cc(-c2cn(COCC[Si](C)(C)C)c(C3COc4ccc(O)cc4C3)n2)n(C)n1.Cc1cc(-c2cn(COCC[Si](C)(C)C)c(C3COc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)n2)n(C)n1.Cc1cc(-c2cnc(C3COc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)[nH]2)n(C)n1.Cc1cc(C)n(C)n1.O=C1CCc2c(F)ccnc2N1.

What is the InChIKey of 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole?

The InChIKey is MJXOJWYBSIPELR-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H38N6O4Si.C25H24N6O3.C23H32N4O3Si.C18H25BrN2O3Si.C8H7FN2O.C6H10N2/c1-20-14-26(36(2)35-20)25-17-37(19-39-12-13-42(3,4)5)31(33-25)22-15-21-16-23(6-8-27(21)40-18-22)41-28-10-11-32-30-24(28)7-9-29(38)34-30;1-14-9-20(31(2)30-14)19-12-27-24(28-19)16-10-15-11-17(3-5-21(15)33-13-16)34-22-7-8-26-25-18(22)4-6-23(32)29-25;1-16-10-21(26(2)25-16)20-13-27(15-29-8-9-31(3,4)5)23(24-20)18-11-17-12-19(28)6-7-22(17)30-14-18;1-25(2,3)7-6-23-12-21-10-17(19)20-18(21)14-8-13-9-15(22)4-5-16(13)24-11-14;9-6-3-4-10-8-5(6)1-2-7(12)11-8;1-5-4-6(2)8(3)7-5/h6,8,10-11,14,16-17,22H,7,9,12-13,15,18-19H2,1-5H3,(H,32,34,38);3,5,7-9,11-12,16H,4,6,10,13H2,1-2H3,(H,27,28)(H,26,29,32);6-7,10,12-13,18,28H,8-9,11,14-15H2,1-5H3;4-5,9-10,14,22H,6-8,11-12H2,1-3H3;3-4H,1-2H2,(H,10,11,12);4H,1-3H3.

What are the key properties of 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole?

3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole has a molecular weight of 2185.61 g/mol, XLogP of 20.46, 26 rotatable bonds, 6 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for 3-[4-bromo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[5-(2,5-dimethylpyrazol-3-yl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-ol;5-[[3-[4-(2,5-dimethylpyrazol-3-yl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one;5-fluoro-3,4-dihydro-1H-1,8-naphthyridin-2-one;1,3,5-trimethylpyrazole is sourced from PubChem (CID 163775315), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).